I last reviewed Zoom Video Communications (ZM) in this November 21, 2023 post at which time the most current results were for Q3 and YTD2024. On February 26, while in transit to British Columbia for a ski trip, ZM released its Q4 and FY2024 results. Now that I have had the time to analyze ZM's [...]
In my March 21 post, I disclosed the addition of Veeva Systems (VEEV) to the FFJ Portfolio. When I wrote that post, I had recently returned from a ski trip. Shares were trading at ~$230 and I deemed shares to be at the top end of fair valuation. I, however, had initiated a 100 share [...]
I last reviewed Paychex (PAYX) in this December 21, 2023 post at which time Q2 and YTD2024 results and an update to the FY2024 outlook had just been released. With the release of Q3 results and updated FY2024 outlook on April 2, I revisit this existing holding. Business Overview A Business Overview is provided [...]
This FFJ Portfolio - March 2024 report recaps my investment activity during the month of March. A snapshot of the holdings within the portfolio at the end of each month from December 2018 to March 2024 is accessible here. In December 2018, the FFJ Portfolio totals were: Core Accounts: ~$350,809 CDN and ~$418,907 USD Side [...]
In my March 28 Automatic Data Processing (ADP) Is Overvalued guest post at Dividend Power, I lay out my rationale for not wanting to add to my current exposure. I have no idea how ADP's share price will behave in the very short term. I am, however, reasonably confident its share price will be higher [...]
I last reviewed Nike (NKE) in this December 22, 2023 post at which time I concluded that NKE's valuation did not warrant the purchase of additional shares. Now that NKE has released its Q3 and YTD2024 results and FY2024 outlook on March 21, I revisit this existing holding. In my opinion, the time to invest [...]
This FFJ Portfolio - February 2024 report recaps my investment activity during the month and in the first few days of March while I was on a ski trip. A snapshot of the holdings within the portfolio at the end of each month from December 2018 to February 29 is accessible here. In December 2018, [...]
In my December 26, 2023 Veeva Systems (VEEV) post, I stated VEEV was on my 'Watch List'. In hindsight, I should have just acquired shares. Fast forward to February 29, and VEEV released its Q4 and FY2024 results and FY2025 guidance while I was on my ski trip to various resorts in British Columbia. Following [...]
I last reviewed Mastercard (MA) in my June 8, 2023 guest post at Dividend Power. At the time, the most recently available financial results were for Q1 2023. Now, based on my analysis of Q4 and FY2023 results and FY2024 outlook that were released on January 31, I conclude that Mastercard is unreasonably valued. In [...]
I initiated a West Pharmaceutical (WST) position on November 25, 2022 with the purchase of 100 shares @ ~$225 in a 'Core' account within the FFJ Portfolio. I would have acquired more shares but we had just closed the purchase of an additional property which put a dent in my liquidity. By the time I [...]